Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GAD65”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Study completedNCT00435981
What this trial is testing

Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Diamyd Therapeutics AB 70
Early research (Phase 1)Study completedNCT02352974
What this trial is testing

GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)

Who this might be right for
Diabetes Mellitus, Type 1
Johnny Ludvigsson 12
Testing effectiveness (Phase 2)Ended earlyNCT00837759
What this trial is testing

Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus Type 1Autoimmune Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 7
Not applicableLooking for participantsNCT05017142
What this trial is testing

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Who this might be right for
Optic NeuritisTransverse MyelitisAcute Disseminated Encephalomyelitis+15 more
University of Bern 500
Not applicableLooking for participantsNCT07133113
What this trial is testing

Medium-term Effects of Treatments in Autoimmune Encephalitis

Who this might be right for
NMDAR Autoimmune EncephalitisLGI1 Antibody Associated EncephalitisCASPR2-Antibody+3 more
Hospices Civils de Lyon 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05683990
What this trial is testing

Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Autoimmune DiseasesPrevention
Diamyd Medical AB 5
Testing effectiveness (Phase 2)WithdrawnNCT05361447
What this trial is testing

Diazepam Trial in GAD65 Associated Epilepsy

Who this might be right for
GAD 65 Antibody-associated Epilepsy
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT03345004
What this trial is testing

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes MellitusAutoimmune Diseases+9 more
Diamyd Medical AB 109
Testing effectiveness (Phase 2)Study completedNCT05351879
What this trial is testing

Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Linkoeping University 6
Testing effectiveness (Phase 2)Study completedNCT01785108
What this trial is testing

DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen

Who this might be right for
Diabetes Mellitus, Type 1
Johnny Ludvigsson 60
Large-scale testing (Phase 3)Ended earlyNCT05018585
What this trial is testing

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Diamyd Medical AB 321
Testing effectiveness (Phase 2)Study completedNCT02464033
What this trial is testing

EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Johnny Ludvigsson 20